Clinical Trial Update: Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of thioctic acid for diabetic polyneuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Polyneuropathy

Drugs mentioned

• thioctic acid (thioctic acid)

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Diabetic Polyneuropathy | Phase 3 | Status: COMPLETED